Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|May 20, 2026
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumorsViktoria Chirico, Niklas Jahn, Seyma Büyücek, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 21, 2022
Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumorsMaximilian Lennartz, Verena Sofia Ullmann, Natalia Gorbokon, et al.
Experimental and Molecular Pathology|March 30, 2023
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladderPaul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, et al.
Molecular and Cellular Endocrinology|August 3, 2022
Synaptophysin and chromogranin A expression analysis in human tumorsRia Uhlig, David Dum, Natalia Gorbokon, et al.
Human Pathology|November 21, 2024
PAX6 is a useful marker for pancreatic origin of neuroendocrine neoplasms: A tissue microarray study evaluating more than 19,000 tumors from 150 different tumor typesFlorian Lutz, Sophie-Marie Hornburg, Katharina Möller, et al.
Pathology International|April 14, 2023
Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumorsSebastian Dwertmann Rico, Sebastian J A Schliesser, Natalia Gorbokon, et al.
Experimental and Molecular Pathology|November 26, 2025
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancerVictoria Chirico, Tabea Lenkeit, Seyma Büyücek, et al.
Biomedicines|July 29, 2025
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 TumorsMaria Christina Tsourlakis, Simon Kind, Sebastian Dwertmann Rico, et al.
Genes, Chromosomes & Cancer|September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder CarcinomasMartina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer|April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancersHenning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|May 20, 2026
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumorsViktoria Chirico, Niklas Jahn, Seyma Büyücek, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 21, 2022
Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumorsMaximilian Lennartz, Verena Sofia Ullmann, Natalia Gorbokon, et al.
Experimental and Molecular Pathology|March 30, 2023
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladderPaul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, et al.
Molecular and Cellular Endocrinology|August 3, 2022
Synaptophysin and chromogranin A expression analysis in human tumorsRia Uhlig, David Dum, Natalia Gorbokon, et al.
Human Pathology|November 21, 2024
PAX6 is a useful marker for pancreatic origin of neuroendocrine neoplasms: A tissue microarray study evaluating more than 19,000 tumors from 150 different tumor typesFlorian Lutz, Sophie-Marie Hornburg, Katharina Möller, et al.
Pathology International|April 14, 2023
Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumorsSebastian Dwertmann Rico, Sebastian J A Schliesser, Natalia Gorbokon, et al.
Experimental and Molecular Pathology|November 26, 2025
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancerVictoria Chirico, Tabea Lenkeit, Seyma Büyücek, et al.
Biomedicines|July 29, 2025
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 TumorsMaria Christina Tsourlakis, Simon Kind, Sebastian Dwertmann Rico, et al.
Genes, Chromosomes & Cancer|September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder CarcinomasMartina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer|April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancersHenning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
Pageof 12